Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek Ltd has informed the BSE that its trading window for dealing in company securities will be closed from January 1, 2026 until 48 hours after the declaration of unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. The closure applies to all designated persons, their immediate relatives, and connected persons covered under the company's insider trading code. This is a routine compliance filing under SEBI's Prohibition of Insider Trading Regulations, 2015, ahead of the Q3 FY26 earnings announcement. The exact date of the board meeting to approve these results will be communicated separately.
No direct impact on shareholders or stock price — this is a standard regulatory disclosure. However, it signals that Q3 FY26 results are due soon, which could be a potential catalyst depending on the numbers declared.